[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"neurodermatitis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:neurodermatitis":56},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":34,"overallStatus":44,"whyStopped":4,"lastUpdateSubmitDate":45,"lastUpdatePostDateStruct":46,"startDateStruct":49,"completionDateStruct":51,"leadSponsor":53,"locationsCount":4},"100637488",false,"NCT07580911","Efficacy and Safety of HA35 Gel for Ultra-Rapid Skin Pruritus Relief","A Prospective, Single-Arm, Open-Label Pilot Clinical Study to Evaluate Efficacy and Safety of Topical 10% 35 kDa Hyaluronan (HA35) Gel for Ultra-Rapid Relief of Diverse Etiology Skin Pruritus","HA35-ITCH","Inclusion Criteria:\n\n* Age 18-65 years, male or female\n* Moderate-to-severe skin pruritus (NRS ≥6) due to eczema, neurodermatitis, insect bites, urticaria, or postoperative wound itch\n* Able to understand and complete NRS assessments independently\n* Signed written informed consent\n\nExclusion Criteria:\n\n* Topical corticosteroid\u002Fantihistamine use within 2 weeks\n* Infected, broken, or exudative skin lesions at the application site\n* Known hypersensitivity to hyaluronan or gel components\n* Severe systemic disease or immune dysfunction\n* Pregnant or lactating women","ALL","18 Years","65 Years",{"count":20,"type":21},30,"ESTIMATED","INTERVENTIONAL",[24],"NA","This is a prospective, single-arm, open-label, pilot clinical study to evaluate the efficacy and safety of topical 10% high-concentration 35 kDa hyaluronan (HA35) gel for ultra-rapid relief of moderate-to-severe skin pruritus from diverse etiologies (eczema, neurodermatitis, insect bites, urticaria, postoperative wound itch). Eligible participants will receive a single topical application of HA35 gel. The primary objective is to assess pruritus relief at 10 seconds, 45 minutes, 8 hours, 12 hours, and 24 hours post-application. Safety and local skin tolerability will be evaluated throughout the observation period. This is a minimal-risk, non-pharmacological, non-invasive intervention.",[27,28,29,30,31,32,33],"Skin Pruritus","Itch","Eczema Itch","Neurodermatitis","Insect Bite Itch","Urticaria","Postoperative Wound Pruritus",[35,36,37,38,27,39,40,41,42,43],"Hyaluronan","35 kDa Hyaluronan","HA35","Topical Gel","Itch Relief","Ultra-Rapid Relief","Anti-Pruritus","Non-Steroidal","Pilot Clinical Study","NOT_YET_RECRUITING","2026-05-05",{"date":47,"type":48},"2026-05-12","ACTUAL",{"date":50,"type":21},"2026-06-20",{"date":52,"type":21},"2026-08-20",{"name":54,"class":55},"Nakhia Impex LLC","INDUSTRY",""]